<i>Limosilactobacillus reuteri</i> DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial.

Gut Microbes · 2023 · PMC10321188 · PMID 37401761

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.080so close (0.05 < p ≤ 0.1)

The median serum anti-S IgG titer was 609 (168–1,480) BAU/ml in the active treatment arm ( n = 6) which was higher than in the placebo arm (111 [36.1–1,210] BAU/ml, n = 6) but this difference did not reach statistical significance ( p = 0.080) ( Figure 2a ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.